TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4
Turkish Journal of Gastroenterology
  1. Home
  2. Search
Search Results
Total of 5 results
Ranking
Release Date Sort Sort Article Type

Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, The Study Group for Viral Hepatitis of The Turkish Society of Clinical Microbiology and Infectious Diseases

(Turk J Gastroenterol 2019; 30: 10-15) DOI: 10.5152/tjg.2019.07

Abstract Full Text ( PDF) Related Articles

Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience

Nilay Danis, Husnu Pullukcu, Tansu Yamazhan, Galip Ersoz, Nalan Gülsen Unal, Fulya Gunsar, Ilker Turan, Zeki Karasu, Ulus Salih Akarca

(Turk J Gastroenterol 2019; 30: 18-19) DOI: 10.5152/tjg.2019.09

Abstract Full Text ( PDF) Related Articles

Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure

Fatih Güzelbulut, Ekrem Aslan, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Halil Şahin, Mevlüt Kiyak, Emine Kanatsız, Mustafa Keçeci

(Turk J Gastroenterol 2019; 30: 31-32) DOI: 10.5152/tjg.2019.18

Abstract Full Text ( PDF) Related Articles
EISSN 2148-5607